These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25382544)

  • 1. Identification of AREG and PLK1 pathway modulation as a potential key of the response of intracranial 9L tumor to microbeam radiation therapy.
    Bouchet A; Sakakini N; Atifi ME; Le Clec'h C; Bräuer-Krisch E; Rogalev L; Laissue JA; Rihet P; Le Duc G; Pelletier L
    Int J Cancer; 2015 Jun; 136(11):2705-16. PubMed ID: 25382544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pulsed, spatially fractionated, microscopic synchrotron X-ray beams on normal and tumoral brain tissue.
    Bräuer-Krisch E; Serduc R; Siegbahn EA; Le Duc G; Prezado Y; Bravin A; Blattmann H; Laissue JA
    Mutat Res; 2010; 704(1-3):160-6. PubMed ID: 20034592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchrotron microbeam radiation therapy for rat brain tumor palliation-influence of the microbeam width at constant valley dose.
    Serduc R; Bouchet A; Bräuer-Krisch E; Laissue JA; Spiga J; Sarun S; Bravin A; Fonta C; Renaud L; Boutonnat J; Siegbahn EA; Estève F; Le Duc G
    Phys Med Biol; 2009 Nov; 54(21):6711-24. PubMed ID: 19841517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early gene expression analysis in 9L orthotopic tumor-bearing rats identifies immune modulation in molecular response to synchrotron microbeam radiation therapy.
    Bouchet A; Sakakini N; El Atifi M; Le Clec'h C; Brauer E; Moisan A; Deman P; Rihet P; Le Duc G; Pelletier L
    PLoS One; 2013; 8(12):e81874. PubMed ID: 24391709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better Efficacy of Synchrotron Spatially Microfractionated Radiation Therapy Than Uniform Radiation Therapy on Glioma.
    Bouchet A; Bräuer-Krisch E; Prezado Y; El Atifi M; Rogalev L; Le Clec'h C; Laissue JA; Pelletier L; Le Duc G
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1485-1494. PubMed ID: 27325483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain tumor vessel response to synchrotron microbeam radiation therapy: a short-term in vivo study.
    Serduc R; Christen T; Laissue J; Farion R; Bouchet A; Sanden Bv; Segebarth C; Bräuer-Krisch E; Le Duc G; Bravin A; Rémy C; Barbier EL
    Phys Med Biol; 2008 Jul; 53(13):3609-22. PubMed ID: 18560052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of survival of 9L gliosarcoma bearing rats following intracerebral delivery of drugs in combination with microbeam radiation therapy.
    Régnard P; Bräuer-Krisch E; Troprès I; Keyriläinen J; Bravin A; Le Duc G
    Eur J Radiol; 2008 Dec; 68(3 Suppl):S151-5. PubMed ID: 18635331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeability of Brain Tumor Vessels Induced by Uniform or Spatially Microfractionated Synchrotron Radiation Therapies.
    Bouchet A; Potez M; Coquery N; Rome C; Lemasson B; Bräuer-Krisch E; Rémy C; Laissue J; Barbier EL; Djonov V; Serduc R
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1174-1182. PubMed ID: 28721902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First experimental measurement of the effect of cardio-synchronous brain motion on the dose distribution during microbeam radiation therapy.
    Duncan M; Donzelli M; Pellicioli P; Brauer-Krisch E; Davis JA; Lerch MLF; Rosenfeld AB; Petasecca M
    Med Phys; 2020 Jan; 47(1):213-222. PubMed ID: 31680274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchrotron microbeam radiation therapy induces hypoxia in intracerebral gliosarcoma but not in the normal brain.
    Bouchet A; Lemasson B; Christen T; Potez M; Rome C; Coquery N; Le Clec'h C; Moisan A; Bräuer-Krisch E; Leduc G; Rémy C; Laissue JA; Barbier EL; Brun E; Serduc R
    Radiother Oncol; 2013 Jul; 108(1):143-8. PubMed ID: 23731617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical physics aspects of the synchrotron radiation therapies: Microbeam radiation therapy (MRT) and synchrotron stereotactic radiotherapy (SSRT).
    Bräuer-Krisch E; Adam JF; Alagoz E; Bartzsch S; Crosbie J; DeWagter C; Dipuglia A; Donzelli M; Doran S; Fournier P; Kalef-Ezra J; Kock A; Lerch M; McErlean C; Oelfke U; Olko P; Petasecca M; Povoli M; Rosenfeld A; Siegbahn EA; Sporea D; Stugu B
    Phys Med; 2015 Sep; 31(6):568-83. PubMed ID: 26043881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing dose enhancement with Ta
    Engels E; Corde S; McKinnon S; Incerti S; Konstantinov K; Rosenfeld A; Tehei M; Lerch M; Guatelli S
    Phys Med; 2016 Dec; 32(12):1852-1861. PubMed ID: 27866898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meloxicam can Potentiate the Therapeutic Effects of Synchrotron Microbeam Radiation Therapy on High-Grade Glioma Bearing Rats.
    Bouchet A; Le Clec'h C; Rogalev L; Le Duc G; Pelletier L
    Radiat Res; 2022 Jun; 197(6):655-661. PubMed ID: 35245385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil-Associated Gene Pathways but not Eosinophil Numbers are Differentially Regulated between Synchrotron Microbeam Radiation Treatment and Synchrotron Broad-Beam Treatment by 48 Hours Postirradiation.
    Ibahim MJ; Yang Y; Crosbie JC; Stevenson A; Cann L; Paiva P; Rogers PA
    Radiat Res; 2016 Jan; 185(1):60-8. PubMed ID: 26720800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma vascular networks.
    Bouchet A; Lemasson B; Le Duc G; Maisin C; Bräuer-Krisch E; Siegbahn EA; Renaud L; Khalil E; Rémy C; Poillot C; Bravin A; Laissue JA; Barbier EL; Serduc R
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1503-12. PubMed ID: 20932689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchrotron X-Ray Boost Delivered by Microbeam Radiation Therapy After Conventional X-Ray Therapy Fractionated in Time Improves F98 Glioma Control.
    Potez M; Bouchet A; Flaender M; Rome C; Collomb N; Grotzer M; Krisch M; Djonov V; Balosso J; Brun E; Laissue JA; Serduc R
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):360-369. PubMed ID: 32088292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRT-boost as the last fraction may be the most efficient irradiation schedule for increased survival times in a rat glioma model.
    Serduc R; Bouchet A
    J Synchrotron Radiat; 2023 May; 30(Pt 3):591-595. PubMed ID: 37067258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of rats bearing advanced intracerebral F 98 tumors after glutathione depletion and microbeam radiation therapy: conclusions from a pilot project.
    Schültke E; Bräuer-Krisch E; Blattmann H; Requardt H; Laissue JA; Hildebrandt G
    Radiat Oncol; 2018 May; 13(1):89. PubMed ID: 29747666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of rat intracranial 9L gliosarcoma to microbeam radiation therapy.
    Dilmanian FA; Button TM; Le Duc G; Zhong N; Peña LA; Smith JA; Martinez SR; Bacarian T; Tammam J; Ren B; Farmer PM; Kalef-Ezra J; Micca PL; Nawrocky MM; Niederer JA; Recksiek FP; Fuchs A; Rosen EM
    Neuro Oncol; 2002 Jan; 4(1):26-38. PubMed ID: 11772430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-precision radiosurgical dose delivery by interlaced microbeam arrays of high-flux low-energy synchrotron X-rays.
    Serduc R; Bräuer-Krisch E; Siegbahn EA; Bouchet A; Pouyatos B; Carron R; Pannetier N; Renaud L; Berruyer G; Nemoz C; Brochard T; Rémy C; Barbier EL; Bravin A; Le Duc G; Depaulis A; Estève F; Laissue JA
    PLoS One; 2010 Feb; 5(2):e9028. PubMed ID: 20140254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.